Park Ridge, ILNCT07143019Now EnrollingIRB Ready

Hemorrhagic Stroke Clinical Trial in Park Ridge, IL

Access cutting-edge hemorrhagic stroke treatment through this clinical trial at a research site in Park Ridge. Study-provided care at no cost to qualified participants.

Sponsored by phenox Inc.

Quick Self-Assessment

See if you qualify for this Park Ridge location

Preparing your pre-screening questions…

Expert Care in Park Ridge

Access hemorrhagic stroke specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hemorrhagic stroke treatment provided free

Apply for This Park Ridge Location

Check if you qualify for this hemorrhagic stroke clinical trial in Park Ridge, IL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Park Ridge

    Convenient for IL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Park Ridge site if eligible
  4. 4Begin participation

About This Hemorrhagic Stroke Study in Park Ridge

To determine safety and effectiveness of the p48 MW HPC and p64 MW HPC Flow Modulation Device in the treatment of wide-necked intracranial aneurysms.

Sponsor: phenox Inc.

Who Can Participate

Inclusion Criteria

Subject is ≥ 18 years
Subject has a mRS ≤2 before the index procedure
Subject has an unruptured or recanalized intracranial aneurysm (IA). The subject may also have a previous ruptured aneurysm, provided rupture of this aneurysm has occurred more than 30 days from the index procedure. The IA must have the following characteristics below:
Saccular or fusiform morphology
Located in the internal carotid artery and its branches
Aneurysm neck ≥4 mm or dome-to-neck ratio \<2
Parent vessel diameter ≥2.0mm and ≤5.0mm both distal and proximal to the target IA
Subject or subject's legally authorized representative (LAR) has provided written informed consent and has agreed to comply with study procedures.

Exclusion Criteria

Previous flow diverter or stent within the parent vessel of the target aneurysm to be treated
Any other known IA requiring treatment within 3 months post-procedure
Subarachnoid hemorrhage in the past 30 days prior to the index procedure
Has a true bifurcation aneurysm, defined as an aneurysm (saccular or non-saccular) located at the point of vessel bifurcation
Anatomy unsuitable for endovascular procedure due to severe vessel tortuosity or stenosis, or stented ipsilateral carotid artery within 3 months prior to the index procedure
Subject with a brain arteriovenous malformation (AVM) or other vascular malformation in the area of the target aneurysm
Major surgery in the last 30 days, including endovascular procedures, or is planned in the next 90 days after enrollment date
Unstable neurologic deficit (i.e., any worsening of clinical condition in the last 30 days)
Known serious sensitivity to radiographic contrast agents that cannot be managed medically
Known sensitivity to nickel, titanium metals or their alloys or any other investigational device components
Irreversible bleeding disorder and/or signs of active bleeding at subject presentation
Known renal failure with a serum creatinine \>2.5 mg/dl (or 220 μmol/l) not on dialysis
Contraindication to CT scan, MRI, or angiography
Contraindication or known allergies to anticoagulants or antiplatelets (e.g. aspirin, heparin, clopidogrel, prasugrel, or ticagrelor)
Known coagulopathy, or an admission International Normalized Ratio \>3.0 without oral anticoagulation therapy, or an admission platelet count of \<100000
Has acute life-threatening illness other than the neurological disease (i.e., acute kidney or heart failure) to be treated in this trial
Unable to complete the required study follow-ups
Evidence of active infection at the time of treatment (e.g., fever, elevated white blood cell count)
Participating in another clinical trial that could affect participation or primary outcomes of this study
Women currently pregnant or wish to become pregnant during the study or breast feeding.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Park Ridge?

Yes, this clinical trial (NCT07143019) has an active research site in Park Ridge, IL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Hemorrhagic Stroke Treatment Options in Park Ridge, IL

If you're searching for hemorrhagic stroke treatment options in Park Ridge, IL, this clinical trial (NCT07143019) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Park Ridge research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hemorrhagic stroke specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all hemorrhagic stroke clinical trials near you to find additional studies recruiting in your area.

More Stroke Trials in Park Ridge, IL

See all stroke clinical trials recruiting in Park Ridge — not just this study.

Browse Stroke Trials in Park Ridge →

Browse More Trials by Condition

Stroke TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Park Ridge?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Park Ridge, IL